Skip to content

Homeopathic medicines for wrist ganglion

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in reducing the lesion size of dorsal wrist ganglion in adults - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063897
Enrollment
36
Registered
2024-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M659- Synovitis and tenosynovitis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (CH). Each dose will con
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
duration of therapy: 6 months Control Intervention1: Identical- looking placebos: This arm will receive placebo, identical in appearance from verum. Each dose of placebo shall consist of 4 globules (n
dosage and repetition depending upon the individual requirement of the cases. All the medicines and sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. Route of admi

Sponsors

D. N. De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with wrist ganglion (ICD-11 Code FB42.2) clinically and by USG. 2. Age 18- 65 years 3. Participants of either sex or transgender 4. Participants having prior experience or knowledge of the treatment. e.g. primed to expect homoeopathic aggravation and available treatment options for the disease conditions, intimated through Patient Information Sheet

Exclusion criteria

Exclusion criteria: 1. Not providing written informed consent of participation. 2. Non-ambulant patients. 3. Patient suffering from active or chronic, systemic or local infection or disease. 4. Patients who are too sick for consultation. 5. Unwilling to take part and not giving consent to join the study 6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life. 7. Pregnancy, puerperal women and lactating mother. 8. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool) [21]. 9. Self-reported immune-compromised state, AIDS, hepatitis etc. 10. Undergoing homoeopathic treatment for any chronic disease within last 6 months. 11. Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
The size (diameter and height) of the lesion, measured with slide calipersTimepoint: Baseline, every month, up to 6 months

Secondary

MeasureTime frame
MWS- Mayo Wrist ScoreTimepoint: Baseline, every month, up to 6 months;MYMOP-2- Measure Yourself Medical Outcome ProfileTimepoint: Baseline, every month, up to 6 months;PRWE- Patient-Rated Wrist EvaluationTimepoint: Baseline, every month, up to 6 months

Countries

India

Contacts

Public ContactDr Rajat Kumar Pal

D. N. De Homoeopathic Medical College and Hospital

drrajatkumarpal@gmail.com9433130996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026